Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nishit Modi
Pharmacokinetics, Pharmacodynamics and Tolerability of a Potent, Non-Peptidic, GP IIb/IIIa Receptor Antagonist Following Multiple Oral Administrations of a Prodrug Form
Thrombosis and Haemostasis
Hematology
Related publications
Pharmacokinetics and Pharmacodynamics of Tecarfarin, a Novel Vitamin K Antagonist Oral Anticoagulant
Thrombosis and Haemostasis
Hematology
Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
Clinical Pharmacokinetics
Pharmacology
Pharmacokinetics, Safety and Tolerability of L-3-N-Butylphthalide Tablet After Single and Multiple Oral Administrations in Healthy Chinese Volunteers
Brazilian Journal of Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker
Clinical Cancer Research
Cancer Research
Oncology
Pharmacokinetics and Pharmacodynamics of Verapamil Following Sublingual and Oral Administration to Healthy Volunteers.
British Journal of Clinical Pharmacology
Pharmacology
Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Off-Target Effects of Glycoprotein IIb/IIIa Receptor Inhibitors
Cardiology Journal
Medicine
Cardiovascular Medicine
Cardiology
Oral Administration of the GnRH Antagonist Acyline, in a GIPET®-enhanced Tablet Form, Acutely Suppresses Serum Testosterone in Normal Men: Single-Dose Pharmacokinetics and Pharmacodynamics
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese Subjects
Drugs in R and D
Pharmacology
